Back

Association of coagulation markers and antiphospholipid antibodies with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention

26 August 2022 (14:15 - 14:55)
Organised by:
Congress Presentation Part of: Coronary artery disease - Different aspects Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Viktoria Anfang

Heart Center, University of Freiburg, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
Doctor L. Esposito (Salerno, IT)
Abstract Slides
Presentation thumbnail
Epicardial adipose tissue, infarct size, microvascular obstruction and ventricular remodelling after ST-segment elevation myocardial infarction
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
Prognostic implication of residual inflammatory risk according to disease status in patients treated with percutaneous coronary intervention
Doctor H. Song (Gwangmyeong, KR)
Abstract Slides
Presentation thumbnail
Platelet extracellular vesicles are superior to cardiac troponin to diagnose acute coronary syndrome with short symptom duration: LEMONADE trial
Doctor A. Gasecka (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Multivessel spontaneous coronary artery dissection: clinical features, angiographic findings, management, and outcomes
Doctor J. Salamanca Viloria (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Different aspects

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources